Novanta Inc has a consensus price target of $80.5, established from looking at the 2 latest analyst ratings. The last 2 analyst ratings were released from Baird and William Blair on May 11, 2023 and May 11, 2022. With an average price target of $80.5 between Baird and William Blair, there's an implied -51.11% downside for Novanta Inc from these 2 analyst ratings.
1calculated from analyst ratings published within the last 3 years
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/11/2023 | Buy Now | -2.22% | Baird | Robert Mason | $150 → $161 | Maintains | Neutral | Get Alert |
05/11/2022 | Buy Now | — | William Blair | Brian Drab | — | Upgrade | Market Perform → Outperform | Get Alert |
The latest price target for Novanta (NASDAQ: NOVT) was reported by Baird on May 11, 2023. The analyst firm set a price target for $161.00 expecting NOVT to fall to within 12 months (a possible -2.22% downside). 0 analyst firms have reported ratings in the last year.
The latest analyst rating for Novanta (NASDAQ: NOVT) was provided by Baird, and Novanta maintained their neutral rating.
The last upgrade for Novanta Inc happened on May 11, 2022 when William Blair raised their price target to N/A. William Blair previously had a market perform for Novanta Inc.
There is no last downgrade for Novanta.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Novanta, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Novanta was filed on May 11, 2023 so you should expect the next rating to be made available sometime around May 11, 2024.
While ratings are subjective and will change, the latest Novanta (NOVT) rating was a maintained with a price target of $150.00 to $161.00. The current price Novanta (NOVT) is trading at is $164.66, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.